We are live on ! Find out more
INMB icon

INmune Bio
INMB

73 hedge funds and large institutions have $29.5M invested in INmune Bio in 2024 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 35 increasing their positions, 6 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

483% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 6

369% more call options, than puts

Call options by funds: $1.78M | Put options by funds: $379K

88% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 8

9% more funds holding

Funds holding: 67 → 73 (+6)

4.39% more ownership

Funds ownership: 24.15% → 28.54% (+4.4%)

2% more capital invested

Capital invested by funds: $28.8M → $29.5M (+$702K)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
73
Holders Change
+6
Holders Change %
+8.96%
% of All Funds
0.96%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
15
Increased
35
Reduced
6
Closed
8
Calls
$1.78M
Puts
$379K
Net Calls
+$1.4M
Net Calls Change
-$297K

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$485K
2
Millennium Management
Millennium Management
New York
+$463K
3
PHS
Pekin Hardy Strauss
Illinois
+$435K
4
Renaissance Technologies
Renaissance Technologies
New York
+$410K
5
Morgan Stanley
Morgan Stanley
New York
+$328K

Top Sellers

Rank Fund Capital Flow
1
CC
Corton Capital
Ontario, Canada
-$410K
2
HCM
Heights Capital Management
California
-$329K
3
MCM
MAI Capital Management
Ohio
-$313K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$216K
5
Squarepoint
Squarepoint
New York
-$182K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$4.62M +$261K +50,090 +5%
PP
2
Praetorian PR
Puerto Rico
$3.79M +$164K +31,410 +4%
Vanguard Group
3
Vanguard Group
Pennsylvania
$3.45M +$91.2K +17,489 +2%
Raymond James Financial
4
Raymond James Financial
Florida
$2.22M +$2.48M +475,551 New
Geode Capital Management
5
Geode Capital Management
Massachusetts
$1.7M +$99.8K +19,136 +6%
Millennium Management
6
Millennium Management
New York
$1.36M +$463K +88,823 +44%
State Street
7
State Street
Massachusetts
$1.06M – – –
DIG
8
Dauntless Investment Group
New Hampshire
$896K +$1M +191,822 New
Renaissance Technologies
9
Renaissance Technologies
New York
$868K +$410K +78,600 +73%
RPAM
10
Rhenman & Partners Asset Management
Sweden
$833K – – –
Morgan Stanley
11
Morgan Stanley
New York
$724K +$328K +62,982 +68%
GC
12
GatePass Capital
Ohio
$724K +$808K +155,000 New
UBS Group
13
UBS Group
Switzerland
$636K +$485K +93,092 +216%
Deutsche Bank
14
Deutsche Bank
Germany
$513K – – –
Northern Trust
15
Northern Trust
Illinois
$495K +$47.7K +9,154 +9%
MCM
16
MAI Capital Management
Ohio
$471K -$313K -59,991 -37%
WIM
17
Westside Investment Management
California
$420K +$97.3K +18,660 +26%
PHS
18
Pekin Hardy Strauss
Illinois
$389K +$435K +83,350 New
Marshall Wace
19
Marshall Wace
United Kingdom
$362K -$12.6K -2,420 -3%
Two Sigma Investments
20
Two Sigma Investments
New York
$310K +$283K +54,200 +445%
Goldman Sachs
21
Goldman Sachs
New York
$297K +$160K +30,606 +93%
XT
22
XTX Topco
Cayman Islands
$286K +$78.3K +15,018 +32%
Citadel Advisors
23
Citadel Advisors
Florida
$244K +$31.7K +6,081 +13%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$235K +$4.43K +850 +2%
FA
25
Fermata Advisors
California
$219K +$22.2K +4,267 +10%
1
2 3 4

INMB Hedge Fund Activity: Q4 2024 in Review

73 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in INmune Bio (INMB) for Q4 2024, worth a combined $29.5M — up 2.4% from $28.8M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new INMB positions and 8 closed out — a net gain of 7 holders — while 35 added to existing stakes and 6 trimmed.

The largest buyer was UBS Group, adding an estimated $485K. The largest seller was Corton Capital, exiting entirely with an estimated $410K sold.

  • 73 institutional investors held INmune Bio (INMB) as of Q4 2024, up from 67 in Q3 2024.
  • Funds reported $29.5M of INmune Bio stock for Q4 2024, up 2.4% quarter-over-quarter.
  • 15 funds opened new INmune Bio positions in Q4 2024 and 8 closed out, a net change of +7 holders.
  • The largest INmune Bio buyer in Q4 2024 was UBS Group, an estimated $485K added.
  • The largest INmune Bio seller in Q4 2024 was Corton Capital, an estimated $410K sold.

Based on aggregated 13F filings for Q4 2024.